Expand
Resize
Add to favorites
ASC 830-30-45-13 through 45-15 provide guidance on when a reporting entity should include the CTA account balance attributable to a foreign entity in an impairment assessment. This guidance applies to situations when accumulated CTA will be released to income upon the disposition of an investment in a foreign entity. This guidance does not apply to situations involving an investment within a foreign entity.
Based on the guidance in ASC 830-30-45-13 through ASC 830-30-45-15, a reporting entity that has committed to a plan that will result in the reclassification of a CTA account related to an equity-method investment or a consolidated investment in a foreign entity being reclassified to net income should include the CTA account balance in the carrying amount of the investment when evaluating that investment for impairment. Given that the guidance focuses on planned sale transactions of a foreign entity and the CTA relates to the reporting entity’s outside basis investment in a foreign entity, the impairment assessment must be performed in terms of a reporting entity’s reporting currency. This is in contrast to the accounting performed on the individual assets and liabilities within the foreign entity, which must be performed in terms of the foreign entity’s functional currency.

ASC 830-30-45-13

An entity that has committed to a plan that will cause the cumulative translation adjustment for an equity method investment or a consolidated investment in a foreign entity to be reclassified to earnings shall include the cumulative translation adjustment as part of the carrying amount of the investment when evaluating that investment for impairment. The scope of this guidance includes an investment in a foreign entity that is either consolidated by the reporting entity or accounted for by the reporting entity using the equity method. This guidance does not address either of the following:

  1. Whether the cumulative translation adjustment shall be included in the carrying amount of the investment when assessing impairment for an investment in a foreign entity when the reporting entity does not plan to dispose of the investment (that is, the investment or related consolidated assets are held for use)
  2. Planned transactions involving foreign investments that, when consummated, will not cause a reclassification of some amount of the cumulative translation adjustment.

ASC 830-30-45-14

In both cases, paragraph 830-30-40-1 is clear that no basis exists to include the cumulative translation adjustment in an impairment assessment if that assessment does not contemplate a planned sale or liquidation that will cause reclassification of some amount of the cumulative translation adjustment. (If the reclassification will be a partial amount of the cumulative translation adjustment, this guidance contemplates only the cumulative translation adjustment amount subject to reclassification pursuant to paragraphs 830-30-40-2 through 40-4.)

ASC 830-30-45-15

An entity shall include the portion of the cumulative translation adjustment that represents a gain or loss from an effective hedge of the net investment in a foreign operation as part of the carrying amount of the investment when evaluating that investment for impairment.

Example 8-10 illustrates the concepts discussed in ASC 830-30-45-13 through ASC 830-30-45-15 when a reporting entity has committed to a disposal plan resulting in the reclassification of the CTA account to net income. It also addresses the long-lived asset impairment analysis.
EXAMPLE 8-10
Cumulative translation adjustment impairment assessment
USA Corp is a reporting entity located in the United States that has a reporting currency of the US dollar.
Britannia PLC is a wholly-owned subsidiary of USA Corp located in the United Kingdom. It is a distinct and separable operation of USA Corp and has a functional currency of the British pound sterling (GBP). Britannia PLC represents USA Corp’s only foreign entity.
On December 31, 20X5, USA Corp contracts to sell 90% of its interest in Britannia PLC, for USD 100, on January 15, 20X6. USA Corp has an accumulated CTA balance related to its investment in Britannia PLC. Britannia PLC qualifies as an asset held for sale and, based on the guidance in ASC 360, Britannia PLC should be recorded at the lower of its cost or fair value less costs to sell; therefore, an impairment test needs to be conducted as of December 31, 20X5.
How should USA Corp perform the long-lived asset impairment analysis of Britannia PLC?
Analysis
By selling 90% of its ownership interest in Britannia PLC, USA Corp will lose control and deconsolidate Britannia PLC, which results in 100% of the accumulated CTA balance being reclassified to net income upon sale. Accordingly, USA Corp includes 100% of the CTA balance in the Britannia PLC carrying amount when evaluating it for impairment, which necessitates performing the impairment test in USD instead of GBP.
Britannia PLC’s translated USD balance sheet prior to the impairment test (and before classification of the subsidiary as held for sale) is as follows.
Working capital
USD 20
Retained earnings/APIC
USD 140
Long-lived assets
USD 100
CTA
(USD 20)
Total assets
USD 120
Total liabilities and equity
USD 120

For simplicity, any control premium is ignored and the total fair value of the remaining 10% interest is USD 11. The simplified impairment test is calculated as follows:
Working capital
USD 20
Long-lived assets
USD 100
CTA
USD 20
Total carrying value
USD 140
Sale consideration for 90% interest
(USD 100)
Fair value of noncontrolling interest retained
(USD 11)
Loss upon classification as held-for-sale
USD 29
The entries to record the loss upon classification as held for sale as of December 31, 20X5 are as follows:
To classify subsidiary as held for sale:
Dr. Assets held for sale
USD 120
Cr. Working capital
USD 20
Cr. Long-lived assets
USD 100

To record the loss upon classification as held for sale:
Dr. Loss
USD 29
Cr. Assets held for sale
USD 29

At January 15, 20X6, to record the sale and deconsolidation:
Dr. Cash
USD 100
Dr. Noncontrolling investment
USD 11
Cr. CTA
USD 20
Cr. Assets held for sale
USD 91
Expand

Welcome to Viewpoint, the new platform that replaces Inform. Once you have viewed this piece of content, to ensure you can access the content most relevant to you, please confirm your territory.

Your session has expired

Please use the button below to sign in again.
If this problem persists please contact support.

signin option menu option suggested option contentmouse option displaycontent option contentpage option relatedlink option prevandafter option trending option searchicon option search option feedback option end slide